GI
RYTM icon

GAMMA Investing’s Rhythm Pharmaceuticals RYTM Stock Holding History

GAMMA Investing’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4K Buy
364
+97
+36% +$8.77K ﹤0.01% 2445
2026
Q1 		$23.2K Sell
267
-94
-26% -$9.14K ﹤0.01% 2643
2025
Q4 		$38.6K Buy
361
+118
+49% +$12.5K ﹤0.01% 2242
2025
Q3 		$24.5K Buy
243
+32
+15% +$2.97K ﹤0.01% 2421
2025
Q2 		$13.3K Sell
211
-70
-25% -$4.29K ﹤0.01% 2665
2025
Q1 		$14.9K Buy
281
+80
+40% +$4.44K ﹤0.01% 2553
2024
Q4 		$11.3K Buy
201
+80
+66% +$4.42K ﹤0.01% 2548
2024
Q3 		$6.34K Buy
121
+39
+48% +$1.87K ﹤0.01% 2649
2024
Q2 		$3.37K Buy
82
+54
+193% +$2.16K ﹤0.01% 2713
2024
Q1 		$1.21K Buy
28
+15
+115% +$656 ﹤0.01% 2901
2023
Q4 		$573 Buy
+13
New +$410 ﹤0.01% 2932

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GAMMA Investing's RYTM Position: Q2 2026 in Review

GAMMA Investing increased its Rhythm Pharmaceuticals (RYTM) stake by 36% in Q2 2026, buying an estimated $8.77K and bringing the position to 364 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

GAMMA Investing first reported a position in RYTM in Q4 2023 and has held it in 11 quarters since. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • GAMMA Investing held 364 shares of Rhythm Pharmaceuticals worth $40.4K as of Q2 2026.
  • GAMMA Investing bought 97 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $8.77K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2445 holding.
  • GAMMA Investing first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.